Diagnosis of Atrial Fibrillation in Postoperative Thoracic Surgery Using a Smartwatch
Recruiting · NCT06724718 · Interventional (participants receive a specific treatment) · Lead sponsor: Centre Hospitalier Universitaire, Amiens
View the official record on ClinicalTrials.gov →Interventions studied
ECGsmartwatch
What this trial is about
Postoperative atrial fibrillation (POAF) occurs in approximately 20% of patients following thoracic surgery. Early diagnosis is essential to prevent complications such as heart failure, stroke, myocardial infarction, and increased mortality. Smartwatches equipped with single-lead ECG capabilities and algorithms to detect asymptomatic atrial fibrillation (AF) offer a potential solution. This study aims to evaluate the effectiveness of smartwatches in detecting POAF compared to standard care.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Adults (\>18 years old).
- Patients undergoing major thoracic surgery with one-lung ventilation within the past 48 hours.
- Scheduled pneumonectomy or lobectomy.
- Admission to a conventional surgical unit postoperatively.
- Ability to perform single-lead ECG using a smartwatch.
- Coverage under a social security system.
- Signed informed consent
Exclusion criteria
- History of atrial fibrillation.
- Requirement for telemetry for AV block or tachyarrhythmias (\>140 bpm).
- Dependency on a pacemaker.
- Participation in another interventional clinical trial affecting POAF incidence.
- Mediastinal, pleural, or chest wall surgery.
- Reoperations or surgeries performed more than 48 hours prior.
- Pregnant women.
- Patients under guardians or similar legal protection.
Where it is running
1 location listed.
- Centre hospitalier Amiens - Amiens, France